ArticleFrontiers in pain research (Lausanne, Switzerland)2022
Modulation of NMDA receptor activity by CR4056, an imidazoline-2 receptor ligand with analgesic properties.
Giulia Puja et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.